Medications

Capping copays will raise premiums, up drug prices

(HealthDay)—The proposed capping of copays will raise premiums and is likely to increase drug prices, according to a report from the National Center for Policy Analysis (NCPA).

Health

Big premium increases foreseen for Medicare drug plan

With time running out on open enrollment season, many seniors are facing sharply higher premiums for Medicare's popular prescription drug program. The reason: rising drug costs have overtaken a long stretch of stable premiums.

Health

Medicare spending $9B on hepatitis C drugs

Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to new government figures. That's raising insurance costs for all beneficiaries, whether or not they ...

Medications

Prescription drug price battles show no sign of letting up

The decision this week by experts at the Food and Drug Administration to endorse a pair of medicines aimed at combating heart disease brought on the latest round of hand-wringing over prescription drug costs.

Medications

Big cities take aim at prescription painkillers

Some of the nation's largest cities are ratcheting up their criticism of prescription painkillers, blaming the industry for a wave of addiction and overdoses that have ravaged their communities and busted local budgets.

page 7 from 10